Advanced lipoprotein measures and recurrent preterm birth

John M. Thorp*, Madeline Murguia Rice, Margaret Harper, Mark Klebanoff, Yoram Sorokin, Michael W. Varner, Ronald J. Wapner, Steve N. Caritis, Jay D. Iams, Alan M Peaceman, Brian M. Mercer, Anthony Sciscione, Dwight J. Rouse, Susan M. Ramin, Garland B. Anderson

*Corresponding author for this work

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective Lipoproteins are associated with atherogenic and inflammatory processes, and these processes may be related to adverse pregnancy outcomes. We therefore examined whether variations in lipoprotein particle size and concentration are associated with preterm birth (PTB) <35 weeks' gestation. Study Design This is a case-control ancillary study to a randomized trial of omega-3 fatty acid supplementation to prevent recurrent PTB. We measured standard lipids and used nuclear magnetic resonance (NMR) spectroscopy to characterize 17 lipoprotein particles from plasma collected at the baseline randomization visit (16-21 weeks' gestation) in 128 cases (PTB <35 weeks' gestation) and 132 term controls. Logistic regression models controlled for study center, race/ethnicity, number of prior PTB, smoking, and treatment group, as well as total low-density lipoprotein (LDL), high-density lipoprotein, and triglyceride concentrations when examining LDLNMR, high-density lipoproteinNMR, and very LDL (VLDL)NMR, respectively. Results Only 1 of the 17 NMR lipoproteins was associated with recurrent PTB. We observed an increased odds of recurrent PTB of 1.04 (95% confidence interval, 1.01-1.08; P =.02) per nanometer increase in VLDLNMR particle size and an odds ratio of 3.00 (confidence interval, 1.40-6.43; P =.005) for the third tertile of VLDLNMR particle size compared with the first tertile. Conclusion In women with prior PTB, variations in midpregnancy lipoproteins were not associated with recurrent PTB overall, however the association observed with VLDLNMR particle size is suggestive that PTB may be amenable to lifestyle, nutritional, or pharmacologic interventions.

Original languageEnglish (US)
Pages (from-to)342.e1-342.e7
JournalAmerican Journal of Obstetrics and Gynecology
Volume209
Issue number4
DOIs
StatePublished - Jan 1 2013

Fingerprint

Premature Birth
Lipoproteins
Particle Size
Magnetic Resonance Spectroscopy
Pregnancy
Logistic Models
Confidence Intervals
VLDL Lipoproteins
Omega-3 Fatty Acids
HDL Lipoproteins
Pregnancy Outcome
Random Allocation
LDL Lipoproteins
Case-Control Studies
Life Style
Smoking
Odds Ratio
Lipids

Keywords

  • birth
  • lipids
  • nutrition

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Thorp, J. M., Rice, M. M., Harper, M., Klebanoff, M., Sorokin, Y., Varner, M. W., ... Anderson, G. B. (2013). Advanced lipoprotein measures and recurrent preterm birth. American Journal of Obstetrics and Gynecology, 209(4), 342.e1-342.e7. https://doi.org/10.1016/j.ajog.2013.06.005
Thorp, John M. ; Rice, Madeline Murguia ; Harper, Margaret ; Klebanoff, Mark ; Sorokin, Yoram ; Varner, Michael W. ; Wapner, Ronald J. ; Caritis, Steve N. ; Iams, Jay D. ; Peaceman, Alan M ; Mercer, Brian M. ; Sciscione, Anthony ; Rouse, Dwight J. ; Ramin, Susan M. ; Anderson, Garland B. / Advanced lipoprotein measures and recurrent preterm birth. In: American Journal of Obstetrics and Gynecology. 2013 ; Vol. 209, No. 4. pp. 342.e1-342.e7.
@article{7b27042ca9bb4243a4a37695569f1807,
title = "Advanced lipoprotein measures and recurrent preterm birth",
abstract = "Objective Lipoproteins are associated with atherogenic and inflammatory processes, and these processes may be related to adverse pregnancy outcomes. We therefore examined whether variations in lipoprotein particle size and concentration are associated with preterm birth (PTB) <35 weeks' gestation. Study Design This is a case-control ancillary study to a randomized trial of omega-3 fatty acid supplementation to prevent recurrent PTB. We measured standard lipids and used nuclear magnetic resonance (NMR) spectroscopy to characterize 17 lipoprotein particles from plasma collected at the baseline randomization visit (16-21 weeks' gestation) in 128 cases (PTB <35 weeks' gestation) and 132 term controls. Logistic regression models controlled for study center, race/ethnicity, number of prior PTB, smoking, and treatment group, as well as total low-density lipoprotein (LDL), high-density lipoprotein, and triglyceride concentrations when examining LDLNMR, high-density lipoproteinNMR, and very LDL (VLDL)NMR, respectively. Results Only 1 of the 17 NMR lipoproteins was associated with recurrent PTB. We observed an increased odds of recurrent PTB of 1.04 (95{\%} confidence interval, 1.01-1.08; P =.02) per nanometer increase in VLDLNMR particle size and an odds ratio of 3.00 (confidence interval, 1.40-6.43; P =.005) for the third tertile of VLDLNMR particle size compared with the first tertile. Conclusion In women with prior PTB, variations in midpregnancy lipoproteins were not associated with recurrent PTB overall, however the association observed with VLDLNMR particle size is suggestive that PTB may be amenable to lifestyle, nutritional, or pharmacologic interventions.",
keywords = "birth, lipids, nutrition",
author = "Thorp, {John M.} and Rice, {Madeline Murguia} and Margaret Harper and Mark Klebanoff and Yoram Sorokin and Varner, {Michael W.} and Wapner, {Ronald J.} and Caritis, {Steve N.} and Iams, {Jay D.} and Peaceman, {Alan M} and Mercer, {Brian M.} and Anthony Sciscione and Rouse, {Dwight J.} and Ramin, {Susan M.} and Anderson, {Garland B.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.ajog.2013.06.005",
language = "English (US)",
volume = "209",
pages = "342.e1--342.e7",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

Thorp, JM, Rice, MM, Harper, M, Klebanoff, M, Sorokin, Y, Varner, MW, Wapner, RJ, Caritis, SN, Iams, JD, Peaceman, AM, Mercer, BM, Sciscione, A, Rouse, DJ, Ramin, SM & Anderson, GB 2013, 'Advanced lipoprotein measures and recurrent preterm birth', American Journal of Obstetrics and Gynecology, vol. 209, no. 4, pp. 342.e1-342.e7. https://doi.org/10.1016/j.ajog.2013.06.005

Advanced lipoprotein measures and recurrent preterm birth. / Thorp, John M.; Rice, Madeline Murguia; Harper, Margaret; Klebanoff, Mark; Sorokin, Yoram; Varner, Michael W.; Wapner, Ronald J.; Caritis, Steve N.; Iams, Jay D.; Peaceman, Alan M; Mercer, Brian M.; Sciscione, Anthony; Rouse, Dwight J.; Ramin, Susan M.; Anderson, Garland B.

In: American Journal of Obstetrics and Gynecology, Vol. 209, No. 4, 01.01.2013, p. 342.e1-342.e7.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Advanced lipoprotein measures and recurrent preterm birth

AU - Thorp, John M.

AU - Rice, Madeline Murguia

AU - Harper, Margaret

AU - Klebanoff, Mark

AU - Sorokin, Yoram

AU - Varner, Michael W.

AU - Wapner, Ronald J.

AU - Caritis, Steve N.

AU - Iams, Jay D.

AU - Peaceman, Alan M

AU - Mercer, Brian M.

AU - Sciscione, Anthony

AU - Rouse, Dwight J.

AU - Ramin, Susan M.

AU - Anderson, Garland B.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Objective Lipoproteins are associated with atherogenic and inflammatory processes, and these processes may be related to adverse pregnancy outcomes. We therefore examined whether variations in lipoprotein particle size and concentration are associated with preterm birth (PTB) <35 weeks' gestation. Study Design This is a case-control ancillary study to a randomized trial of omega-3 fatty acid supplementation to prevent recurrent PTB. We measured standard lipids and used nuclear magnetic resonance (NMR) spectroscopy to characterize 17 lipoprotein particles from plasma collected at the baseline randomization visit (16-21 weeks' gestation) in 128 cases (PTB <35 weeks' gestation) and 132 term controls. Logistic regression models controlled for study center, race/ethnicity, number of prior PTB, smoking, and treatment group, as well as total low-density lipoprotein (LDL), high-density lipoprotein, and triglyceride concentrations when examining LDLNMR, high-density lipoproteinNMR, and very LDL (VLDL)NMR, respectively. Results Only 1 of the 17 NMR lipoproteins was associated with recurrent PTB. We observed an increased odds of recurrent PTB of 1.04 (95% confidence interval, 1.01-1.08; P =.02) per nanometer increase in VLDLNMR particle size and an odds ratio of 3.00 (confidence interval, 1.40-6.43; P =.005) for the third tertile of VLDLNMR particle size compared with the first tertile. Conclusion In women with prior PTB, variations in midpregnancy lipoproteins were not associated with recurrent PTB overall, however the association observed with VLDLNMR particle size is suggestive that PTB may be amenable to lifestyle, nutritional, or pharmacologic interventions.

AB - Objective Lipoproteins are associated with atherogenic and inflammatory processes, and these processes may be related to adverse pregnancy outcomes. We therefore examined whether variations in lipoprotein particle size and concentration are associated with preterm birth (PTB) <35 weeks' gestation. Study Design This is a case-control ancillary study to a randomized trial of omega-3 fatty acid supplementation to prevent recurrent PTB. We measured standard lipids and used nuclear magnetic resonance (NMR) spectroscopy to characterize 17 lipoprotein particles from plasma collected at the baseline randomization visit (16-21 weeks' gestation) in 128 cases (PTB <35 weeks' gestation) and 132 term controls. Logistic regression models controlled for study center, race/ethnicity, number of prior PTB, smoking, and treatment group, as well as total low-density lipoprotein (LDL), high-density lipoprotein, and triglyceride concentrations when examining LDLNMR, high-density lipoproteinNMR, and very LDL (VLDL)NMR, respectively. Results Only 1 of the 17 NMR lipoproteins was associated with recurrent PTB. We observed an increased odds of recurrent PTB of 1.04 (95% confidence interval, 1.01-1.08; P =.02) per nanometer increase in VLDLNMR particle size and an odds ratio of 3.00 (confidence interval, 1.40-6.43; P =.005) for the third tertile of VLDLNMR particle size compared with the first tertile. Conclusion In women with prior PTB, variations in midpregnancy lipoproteins were not associated with recurrent PTB overall, however the association observed with VLDLNMR particle size is suggestive that PTB may be amenable to lifestyle, nutritional, or pharmacologic interventions.

KW - birth

KW - lipids

KW - nutrition

UR - http://www.scopus.com/inward/record.url?scp=84884673649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884673649&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2013.06.005

DO - 10.1016/j.ajog.2013.06.005

M3 - Article

VL - 209

SP - 342.e1-342.e7

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -

Thorp JM, Rice MM, Harper M, Klebanoff M, Sorokin Y, Varner MW et al. Advanced lipoprotein measures and recurrent preterm birth. American Journal of Obstetrics and Gynecology. 2013 Jan 1;209(4):342.e1-342.e7. https://doi.org/10.1016/j.ajog.2013.06.005